LEADER 03735nam  2200601Ia 450 
001 9910817713803321
005 20230721012427.0
010   $a1-60795-135-5
035   $a(CKB)2560000000052004
035   $a(EBL)3386900
035   $a(SSID)ssj0000371530
035   $a(PQKBManifestationID)11241299
035   $a(PQKBTitleCode)TC0000371530
035   $a(PQKBWorkID)10379835
035   $a(PQKB)10264802
035   $a(MiAaPQ)EBC3386900
035   $a(Au-PeEL)EBL3386900
035   $a(CaPaEBR)ebr10409633
035   $a(OCoLC)923337332
035   $a(EXLCZ)992560000000052004
100   $a20070629d2008      uy         0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aTravelers' Malaria$b[electronic resource] /$fPatricia Schlagenhauf-Lawlor [editor]
205   $a[2nd ed.].
210   $aHamilton, Ont. $cBC Decker Inc.$dc2008
215   $a1 online resource (420 p.)
300   $aDescription based upon print version of record.
311   $a1-55009-336-3 
320   $aIncludes bibilographical references and index.
327   $a""Title and Front matter""; ""Contributors""; ""Foreword to the First Edition""; ""Preface to the First Edition""; ""Preface to the Second Edition""; ""Contents""; ""1. Travelers Malaria: People and Plasmodia: Some Historic Perspectives""; ""2. Global Epidemiology of Malaria""; ""3. Geographical Distribution at Traveler Destinations""; ""4. Evidence of Malaria Exposure in Travelers""; ""5. Network Surveillance of Malaria in Travelers""; ""6. The Parasite""; ""7. Malaria Drug Resistance""; ""8. The Vector and Measures against Mosquito Bites""
327   $a""9. Strategies of Malaria Prevention in Nonimmune Visitors to Endemic Countries""""10. Drugs Used for Malaria Chemoprophylaxis""; ""10.1 Chloroquine and Combinations""; ""10.2 Hydroxychloroquine""; ""10.3 Azithromycin""; ""10.4 Mefloquine""; ""10.5 Doxycyline""; ""10.6 Primaquine""; ""10.7 Atovaquone-Proguanil""; ""10.8 Tafenoquine""; ""11. Malaria Prevention for Particular Travelers""; ""11.1 Long-Term Travelers""; ""11.2 Brief Exposure Malaria Prevention""; ""11.3 Military Perspectives for Malaria Prevention""; ""11.4 Migrants""
327   $a""11.5 Special Groups: Pregnant Women, Infants, and Young Children""""11.6 Immunocompromised Travelers""; ""12. Plasmodium Vivax Malaria: Prevention and Treatment""; ""13. Determination of Antimalarial Drug Levels in Body Fluids""; ""14. Clinical Features of Malaria in Travelers and Migrants""; ""15. Diagnosis of Malaria in Returned Travelers""; ""16. Use of Malaria Rapid Diagnostic Tests for and by Travelers""; ""17. Management of Malaria in Returned Travelers""; ""18. Stand-by Emergency Self-Treatment of Malaria by Travelers""; ""19. Malaria Deaths in Travelers""
327   $a""20. Counterfeit and Substandard Antimalarial Drugs""""21. Odyssean and Non-Mosquito-Transmitted Forms of Malaria""; ""22. The Changing Geography of Malaria""; ""23. Malaria Risk for Travelers to Southern Africa""; ""24. Prospects for a Travelersa??? Malaria Vaccine""; ""25. Imported Malaria""; ""26. Closing the Circle: Compliance and Adherence""; ""Appendix 1""; ""Appendix 2""; ""Index""
606   $aMalaria
606   $aMalaria$xPrevention
606   $aTravel$xHealth aspects
615  0$aMalaria.
615  0$aMalaria$xPrevention.
615  0$aTravel$xHealth aspects.
676   $a614.4
700   $aSchlagenhauf-Lawlor$b Patricia$0902947
701   $aSchlagenhauf-Lawlor$b Patricia$0902947
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910817713803321
996   $aTravelers' Malaria$93920876
997   $aUNINA